AcelRx Pharmaceuticals Shares Outstanding 2009-2019 | ACRX

AcelRx Pharmaceuticals shares outstanding from 2009 to 2019. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
AcelRx Pharmaceuticals Annual Shares Outstanding
(Millions of Shares)
2018 58
2017 47
2016 45
2015 44
2014 44
2013 40
2012 22
2011 17
2010 1
2009 1
2008 0
AcelRx Pharmaceuticals Quarterly Shares Outstanding
(Millions of Shares)
Q3 2019 79
Q2 2019 79
Q1 2019 79
Q4 2018 58
Q3 2018 60
Q2 2018 52
Q1 2018 51
Q4 2017 47
Q3 2017 46
Q2 2017 45
Q1 2017 45
Q4 2016 45
Q3 2016 45
Q2 2016 45
Q1 2016 45
Q4 2015 44
Q3 2015 45
Q2 2015 44
Q1 2015 44
Q4 2014 44
Q3 2014 44
Q2 2014 44
Q1 2014 43
Q4 2013 40
Q3 2013 41
Q2 2013 37
Q1 2013 37
Q4 2012 22
Q3 2012 23
Q2 2012 21
Q1 2012 20
Q4 2011 17
Q3 2011 19
Q2 2011 19
Q1 2011 11
Q4 2010 1
Q3 2010 1
Q2 2010 1
Q1 2010 1
Q4 2009
Q4 2008
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.146B $0.002B
AcelRx Pharmaceuticals, Inc., is a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of pain. The Company product candidates comprises: ARX-01 or the Sufentanil NanoTab PCA System; ARX-02 or the Sufentanil NanoTab BTP Management System; and ARX-03 or the Sufentanil/Triazolam NanoTab which are in their development stage. Its product ARX-01 is focused on acute post-operative pain, ARX-02 is focused on the treatment of cancer breakthrough pain and ARX-03 is focused on providing mild sedation, anxiety reduction, and pain relief to patients undergoing painful procedures in a physician's office. AcelRx Pharmaceuticals, Inc. is headquartered in Redwood City, California.
Stock Name Country Market Cap PE Ratio
Takeda Pharmaceutical (TAK) Japan $63.714B 10.07
Zoetis (ZTS) United States $57.208B 34.22
Astellas Pharma (ALPMY) Japan $32.299B 16.13
Eisai (ESALY) Japan $21.618B 41.69
UCB SA (UCBJF) Belgium $15.697B 0.00
Grifols, S.A (GRFS) Spain $15.387B 20.16
Merck (MKGAF) Germany $14.824B 20.23
Neurocrine Biosciences (NBIX) United States $10.727B 506.43
Ono Pharmaceutical (OPHLF) Japan $9.450B 20.20
Ionis Pharmaceuticals (IONS) United States $9.077B 18.39
IPSEN SA ADR (IPSEY) France $9.039B 0.00
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $8.638B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $8.378B 10.70
Catalent (CTLT) United States $7.550B 30.71
Arrowhead Pharmaceuticals (ARWR) United States $6.272B 94.97
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.263B 0.00
Orion OYJ (ORINY) Finland $5.849B 30.12
STADA ARZNEIMI (STDAF) Germany $5.375B 0.00
Hypermarcas (HYPMY) Brazil $4.851B 17.44
FibroGen (FGEN) United States $4.113B 120.87
United Therapeutics (UTHR) United States $3.959B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.618B 13.22
Nektar Therapeutics (NKTR) United States $3.494B 0.00
Evotec AG (EVTCY) Germany $3.326B 54.42
Sage Therapeutics (SAGE) United States $3.118B 0.00
PTC Therapeutics (PTCT) United States $3.046B 0.00
Heron Therapeutics (HRTX) United States $2.309B 0.00
Xencor (XNCR) United States $2.303B 70.02
Portola Pharmaceuticals (PTLA) United States $2.206B 0.00
Zogenix (ZGNX) United States $2.017B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.934B 61.65
Pacira Pharmaceuticals (PCRX) United States $1.892B 55.99
Tilray (TLRY) Canada $1.848B 0.00
ChemoCentryx (CCXI) United States $1.802B 0.00
USANA Health Sciences (USNA) United States $1.612B 17.20
Corcept Therapeutics (CORT) United States $1.497B 18.19
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.414B 0.00
CLINIGEN GP (CLIGF) United Kingdom $1.244B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.242B 28.37
Theravance Biopharma (TBPH) Cayman Islands $1.191B 0.00
ArQule (ARQL) United States $1.148B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.110B 7.57
Karyopharm Therapeutics (KPTI) United States $1.096B 0.00
Endo (ENDP) Ireland $1.093B 2.01
Spectrum Pharmaceuticals (SPPI) United States $1.073B 0.00
Radius Health (RDUS) United States $1.001B 0.00
Aerie Pharmaceuticals (AERI) United States $0.896B 0.00
Flexion Therapeutics (FLXN) United States $0.725B 0.00
Akebia Therapeutics (AKBA) United States $0.721B 0.00
Collegium Pharmaceutical (COLL) United States $0.680B 0.00
TherapeuticsMD (TXMD) United States $0.648B 0.00
Translate Bio (TBIO) United States $0.583B 0.00
ImmunoGen (IMGN) United States $0.582B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.485B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.485B 58.88
Concordia (CXRXF) Canada $0.473B 0.00
Organogenesis Holdings (ORGO) United States $0.456B 0.00
Harpoon Therapeutics (HARP) United States $0.442B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.440B 0.00
Molecular Templates (MTEM) United States $0.438B 0.00
Dermira (DERM) United States $0.430B 0.00
Ardelyx (ARDX) United States $0.428B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.403B 17.38
Indivior (INVVY) United States $0.390B 1.41
BioCryst Pharmaceuticals (BCRX) United States $0.386B 0.00
DURECT (DRRX) United States $0.383B 0.00
Recro Pharma (REPH) United States $0.369B 0.00
Siga Technologies (SIGA) United States $0.368B 8.41
Innate Pharma SA (IPHYF) France $0.358B 0.00
Lannett Co Inc (LCI) United States $0.342B 3.99
OptiNose (OPTN) United States $0.342B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.342B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.320B 0.00
Rafael Holdings (RFL) United States $0.291B 0.00
GlycoMimetics (GLYC) United States $0.255B 0.00
Jounce Therapeutics (JNCE) United States $0.253B 3.38
Matinas Biopharma Holdings (MTNB) United States $0.252B 0.00
KalVista Pharmaceuticals (KALV) United States $0.252B 0.00
Calithera Biosciences (CALA) United States $0.238B 0.00
Xeris Pharmaceuticals (XERS) United States $0.234B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.216B 0.00
Aquestive Therapeutics (AQST) United States $0.209B 0.00
Ocular Therapeutix (OCUL) United States $0.201B 0.00
Nature's Sunshine Products (NATR) United States $0.189B 32.60
Foamix Pharmaceuticals (FOMX) Israel $0.183B 0.00
Concert Pharmaceuticals (CNCE) United States $0.177B 0.00
Taiwan Liposome (TLC) Taiwan $0.160B 0.00
IMV INC (IMV) Canada $0.144B 0.00
Redhill Biopharma (RDHL) Israel $0.143B 0.00
MEI Pharma (MEIP) United States $0.143B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.143B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.139B 0.00
CannTrust Holdings (CTST) Canada $0.112B 0.00
Cardiome Pharma (CORV) Canada $0.109B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.100B 0.00
CV Sciences (CVSI) United States $0.094B 0.00
Champions Oncology (CSBR) United States $0.085B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.083B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.078B 23.45
Otonomy (OTIC) United States $0.077B 0.00
Neos Therapeutics (NEOS) United States $0.077B 0.00
MediWound (MDWD) Israel $0.074B 0.00
Infinity Pharmaceuticals (INFI) United States $0.071B 0.00
PolarityTE (PTE) United States $0.070B 0.00
Capnia (SLNO) United States $0.069B 0.00
Aclaris Therapeutics (ACRS) United States $0.067B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.066B 0.00
Pharmaxis (PXSLY) Australia $0.065B 0.00
Natural Alternatives (NAII) United States $0.057B 14.27
SCYNEXIS (SCYX) United States $0.057B 0.00
Novan (NOVN) United States $0.057B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.057B 0.00
Genocea Biosciences (GNCA) United States $0.056B 0.00
CTI BioPharma (CTIC) United States $0.056B 0.00
Nivalis Therapeutics (ALPN) United States $0.055B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.055B 0.00
Medicure (MCUJF) Canada $0.054B 0.00
RENEURON GP (RNUGF) United Kingdom $0.052B 0.00
IntelGenx Technologies (IGXT) Canada $0.051B 0.00
Iterum Therapeutics (ITRM) Ireland $0.050B 0.00
ElectroCore (ECOR) United States $0.048B 0.00
AgeX Therapeutics (AGE) United States $0.047B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.047B 0.00
Mast Therapeutics (SVRA) United States $0.046B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.041B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.040B 0.00
IsoRay (ISR) United States $0.039B 0.00
Mannatechorporated (MTEX) United States $0.038B 0.00
Opexa Therapeutics (ACER) United States $0.036B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.034B 0.00
Jaguar Animal Health (JAGX) United States $0.031B 0.00
Biomerica (BMRA) United States $0.029B 0.00
India Globalization Capital (IGC) United States $0.029B 0.00
PharmAthene (ALT) United States $0.028B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.025B 0.00
ProPhase Labs (PRPH) United States $0.024B 0.00
Bio-Path Holdings (BPTH) United States $0.022B 0.00
Shineco (TYHT) China $0.022B 0.00
Melinta Therapeutics (MLNT) United States $0.022B 0.00
China SXT Pharmaceuticals (SXTC) China $0.020B 0.00
Flex Pharma (SLRX) United States $0.017B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.016B 0.00
Regulus Therapeutics (RGLS) United States $0.016B 0.00
Vical (BBI) United States $0.016B 0.00
Heat Biologics (HTBX) United States $0.015B 0.00
VAXART, INC (VXRT) United States $0.015B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.014B 0.00
Cyanotech (CYAN) United States $0.014B 0.00
Lipocine (LPCN) United States $0.010B 0.00
HANCOCK JAFFE (HJLI) United States $0.009B 0.00
Achieve Life Sciences (ACHV) United States $0.008B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.007B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
RXi Pharmaceuticals (PHIO) United States $0.005B 0.00
Can-Fite Biopharma (CANF) Israel $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Hemispherx BioPharma (AIM) United States $0.003B 0.00
Onconova Therapeutics (ONTX) United States $0.002B 0.00
Midatech Pharma (MTP) United Kingdom $0.002B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.001B 0.00
Advanced Accelerator Applications S.A (AAAP) France $0.000B 0.00
Forward Pharma (FWP) Denmark $0.000B 0.00